ARTICLE | Clinical News
Molecular Biosystems regulatory update
October 11, 1993 7:00 AM UTC
Molecular Biosystems Inc. (MB) MB received marketing approval in Japan for its Albunex contrast imaging agent for use with ultrasound. The approval triggered a $5 million milestone payment from licen...